New nano-drug candidate kills destructive breast cancer cells

The researcher's focus is on developing new, targeted photodynamic therapy drugs.

New York: Researchers have developed a new nano-drug candidate that kills triple-negative breast cancer cells, which is one of the most aggressive and fatal types of breast cancer.

The study, published in the journal Advanced Therapeutics, will help clinicians target breast cancer cells directly while avoiding the adverse, toxic side effects of chemotherapy.

The research team linked a new class of nanomaterials, called metal-organic frameworks, with the ligands of an already-developed photodynamic therapy drug to create a nanoporous material that targets and kills tumour cells without creating toxicity for healthy cells.

Metal-organic frameworks are an emerging class of nanomaterials designed for targeted drug delivery. Ligands are molecules that bind to other units,

the study said.

“Patients with triple-negative cells are especially vulnerable, because of the toxic side effects of the only approved treatment for this type of cancer,” said study researcher Hassan Beyzavi from the University of Arkansas in the US.

READ:  Nitin Patel: Partial Rajkot hospital video shared to tarnish health care image

“We’ve addressed this problem by developing a co-formulation that targets cancer cells and has no effect on healthy cells,” Beyzavi added.

The researcher’s focus is on developing new, targeted photodynamic therapy drugs.

As an alternative to chemotherapy — and with significantly fewer side effects — targeted photodynamic therapy, or PDT, is a non-invasive approach that relies on a photosensitizer that, upon irradiation by light, generates so-called toxic reactive oxygen species, which kill cancer cells.

In recent years, PDT has garnered attention because of its ability to treat tumours without surgery, chemotherapy or radiation.

Beyzavi’s laboratory has specialized in integrating nanomaterials, such as metal-organic frameworks, with PDT and other and therapies. Metal-organic structures significantly enhance the effectiveness of PDT.

READ:  Spider venom may work as a painkiller for bowel syndrome

The research team prepared the nanomaterials and then bio-conjugated them with ligands of the PDT drug to create nanoporous materials that specifically targeted and killed tumour cells with no toxicity in healthy cells.

Subscribe us on The Siasat Daily - Google News
Back to top button